141 related articles for article (PubMed ID: 15467768)
21. BRCA1-Associated Protein Increases Invasiveness of Esophageal Squamous Cell Carcinoma.
Zhao Y; Wei L; Shao M; Huang X; Chang J; Zheng J; Chu J; Cui Q; Peng L; Luo Y; Tan W; Tan W; Lin D; Wu C
Gastroenterology; 2017 Nov; 153(5):1304-1319.e5. PubMed ID: 28780075
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma.
Li Y; Ma J; Guo Q; Duan F; Tang F; Zheng P; Zhao Z; Lu G
Dis Esophagus; 2009; 22(8):664-7. PubMed ID: 19191857
[TBL] [Abstract][Full Text] [Related]
23. Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma.
Zhang H; Xu L; Xiao D; Xie J; Zeng H; Cai W; Niu Y; Yang Z; Shen Z; Li E
J Clin Pathol; 2006 Sep; 59(9):958-64. PubMed ID: 16524962
[TBL] [Abstract][Full Text] [Related]
24. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.
Zhang S; Li L; Lin JY; Lin H
World J Gastroenterol; 2003 May; 9(5):899-904. PubMed ID: 12717827
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-30d inhibits the migration and invasion of human esophageal squamous cell carcinoma cells via the post‑transcriptional regulation of enhancer of zeste homolog 2.
Xie R; Wu SN; Gao CC; Yang XZ; Wang HG; Zhang JL; Yan W; Ma TH
Oncol Rep; 2017 Mar; 37(3):1682-1690. PubMed ID: 28184915
[TBL] [Abstract][Full Text] [Related]
26. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
27. Relationship between TWIST expression and epithelial-mesenchymal transition of oesophageal squamous cell carcinoma.
Gao Y; Xuan XY; Zhang HY; Wang F; Zeng QR; Wang ZQ; Li SS
Cell Biol Int; 2012 Jun; 36(6):571-7. PubMed ID: 22360285
[TBL] [Abstract][Full Text] [Related]
28. JAK/STAT signal pathway activation promotes progression and survival of human oesophageal squamous cell carcinoma.
You Z; Xu D; Ji J; Guo W; Zhu W; He J
Clin Transl Oncol; 2012 Feb; 14(2):143-9. PubMed ID: 22301404
[TBL] [Abstract][Full Text] [Related]
29. [Expression of Six1 and Six4 in esophageal squamous cell carcinoma and their correlation with clinical prognosis].
Wei Q; Yu WW; Zhao KL; Fu XL; Zhu ZF; Qin GQ; Chen H; Zhang ZX; Gu YZ; Xiang JQ; Chen HQ; Du X; Sun MH
Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):446-50. PubMed ID: 24246862
[TBL] [Abstract][Full Text] [Related]
30. NF-kappaB signalling proteins p50/p105, p52/p100, RelA, and IKKepsilon are over-expressed in oesophageal squamous cell carcinomas.
Kang MR; Kim MS; Kim SS; Ahn CH; Yoo NJ; Lee SH
Pathology; 2009; 41(7):622-5. PubMed ID: 20001340
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of HSPA2 is correlated with poor prognosis in esophageal squamous cell carcinoma.
Zhang H; Chen W; Duan CJ; Zhang CF
World J Surg Oncol; 2013 Jun; 11():141. PubMed ID: 23777267
[TBL] [Abstract][Full Text] [Related]
32. Prognostic impact of tissue inhibitor of matrix metalloproteinase-1 in esophageal carcinoma.
Mori M; Mimori K; Sadanaga N; Inoue H; Tanaka Y; Mafune K; Ueo H; Barnard GF
Int J Cancer; 2000 Nov; 88(4):575-8. PubMed ID: 11058873
[TBL] [Abstract][Full Text] [Related]
33. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma.
Uchida S; Shimada Y; Watanabe G; Li ZG; Hong T; Miyake M; Imamura M
Br J Cancer; 1999 Mar; 79(7-8):1168-73. PubMed ID: 10098753
[TBL] [Abstract][Full Text] [Related]
34. Rad51 expression is a useful predictive factor for the efficacy of neoadjuvant chemoradiotherapy in squamous cell carcinoma of the esophagus.
Nakanoko T; Saeki H; Morita M; Nakashima Y; Ando K; Oki E; Ohga T; Kakeji Y; Toh Y; Maehara Y
Ann Surg Oncol; 2014 Feb; 21(2):597-604. PubMed ID: 24065387
[TBL] [Abstract][Full Text] [Related]
35. [Expression of activin A in tissue and serum of patients with esophageal squamous cell carcinoma and its clinical significance].
Liu SG; Li HC; Zhao BS; Cao F
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):843-7. PubMed ID: 24447483
[TBL] [Abstract][Full Text] [Related]
36. [Expression level and clinical significance of LncRNA HOXA11-AS in esophageal squamous cell carcinoma patients].
Sun XY; Wang XF; Cui YB; Cao XG; Zhao RH; Wei HY; Cao W; Wu W
Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):186-190. PubMed ID: 29575836
[No Abstract] [Full Text] [Related]
37. Cytokeratin 15 is an Effective Indicator for Progression and Malignancy of Esophageal Squamous Cell Carcinomas.
Shen YH; Xu CP; Shi ZM; Zhang YJ; Qiao YG; Zhao HP
Asian Pac J Cancer Prev; 2016; 17(9):4217-4222. PubMed ID: 27797221
[TBL] [Abstract][Full Text] [Related]
38. Expression of matrix metalloproteinase 2 and its tissue inhibitor in oral squamous cell carcinoma.
Gao ZB; Duan YQ; Zhang L; Chen DW; Ding PT
Int J Mol Med; 2005 Oct; 16(4):599-603. PubMed ID: 16142392
[TBL] [Abstract][Full Text] [Related]
39. Correlation between secreted protein acidic and rich in cysteine protein expression and the prognosis of postoperative patients exhibiting esophageal squamous cell carcinoma.
Wu J; Zhang JR; Jiang XQ; Cao XG
Mol Med Rep; 2017 Sep; 16(3):3401-3406. PubMed ID: 28713937
[TBL] [Abstract][Full Text] [Related]
40. Reduced axin protein expression is associated with a poor prognosis in patients with squamous cell carcinoma of esophagus.
Li AF; Hsu PK; Tzao C; Wang YC; Hung IC; Huang MH; Hsu HS
Ann Surg Oncol; 2009 Sep; 16(9):2486-93. PubMed ID: 19582507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
